Pages that link to "Q40794617"

The following pages link to Identification of methylated CpG motifs as inhibitors of the immune stimulatory CpG motifs. (Q40794617):

Displaying 31 items.

• Nucleic acid sensing receptors in systemic lupus erythematosus: development of novel DNA- and/or RNA-like analogues for treating lupus (Q34017633) (← links)
• Optimal oligonucleotide sequences for TLR9 inhibitory activity in human cells: lack of correlation with TLR9 binding (Q34647633) (← links)
• Aggregation and secondary loop structure of oligonucleotides do not determine their ability to inhibit TLR9 (Q35058952) (← links)
• Traditional biochemical assays for studying toll-like receptor 9. (Q35671392) (← links)
• Immune responses to gene therapy vectors: influence on vector function and effector mechanisms (Q35904408) (← links)
• Inhibitory oligodeoxynucleotides - therapeutic promise for systemic autoimmune diseases? (Q36068780) (← links)
• Microbe-dendritic cell dialog controls regulatory T-cell fate (Q36115730) (← links)
• Toxicity of cationic lipid-DNA complexes (Q36293311) (← links)
• Design of modular non-viral gene therapy vectors. (Q36294162) (← links)
• Gene delivery from polymer scaffolds for tissue engineering (Q36314939) (← links)
• Reducing the immunostimulatory activity of CpG-containing plasmid DNA vectors for non-viral gene therapy (Q36316635) (← links)
• Targeting Toll-like receptor signaling in plasmacytoid dendritic cells and autoreactive B cells as a therapy for lupus. (Q36423215) (← links)
• Plasmid CpG depletion improves degree and duration of tumor gene expression after intravenous administration of polyplexes (Q36738246) (← links)
• Matrices and scaffolds for DNA delivery in tissue engineering (Q36826532) (← links)
• Recent advances in DNA vaccines for autoimmune diseases (Q37386307) (← links)
• Development and validation of an approach to produce large‐scale quantities of CpG‐methylated plasmid DNA (Q37395434) (← links)
• Classification, mechanisms of action, and therapeutic applications of inhibitory oligonucleotides for Toll-like receptors (TLR) 7 and 9. (Q37758263) (← links)
• Essential role of high-mobility group box proteins in nucleic acid-mediated innate immune responses (Q37906759) (← links)
• TLR-9 activation of marginal zone B cells in lupus mice regulates immunity through increased IL-10 production. (Q38329839) (← links)
• Innate immune responses in lupus-prone Palmerston North mice: differential responses to LPS and bacterial DNA/CpG oligonucleotides (Q38353782) (← links)
• Preclinical Biodistribution and Safety Evaluation of a pbi-shRNA STMN1 Lipoplex after Subcutaneous Delivery (Q39213655) (← links)
• 5′‐Phosphate oligodeoxynucleotides enhance the phosphodiester‐CpG DNA‐induced inflammatory response in macrophages (Q39602530) (← links)
• Inhibitory oligodeoxynucleotides downregulate herpes simplex virus-induced plasmacytoid dendritic cell type I interferon production and modulate cell function (Q41824648) (← links)
• Suppression of B-cell activation and IgE, IgA, IgG1 and IgG4 production by mammalian telomeric oligonucleotides (Q44795516) (← links)
• IL-18 gene therapy develops Th1-type immune responses in Leishmania major-infected BALB/c mice: is the effect mediated by the CpG signaling TLR9? (Q45873220) (← links)
• Methylated CpG-containing plasmid activates the immune system (Q47210849) (← links)
• Protein expression following non-viral delivery of plasmid DNA coding for basic FGF and BMP-2 in a rat ectopic model (Q50503457) (← links)
• In vitro induction of T regulatory cells by a methylated CpG DNA sequence in humans: Potential therapeutic applications in allergic and autoimmune diseases. (Q52680941) (← links)
• Synthesis, characterization and evaluation of transfection efficiency of dexamethasone conjugated poly(propyleneimine) nanocarriers for gene delivery# (Q57024029) (← links)
• A role for Toll in autoimmunity (Q78010082) (← links)
• A Dual TLR7/TLR9 Inhibitor HJ901 Inhibits ABC-DLBCL Expressing the MyD88 L265P Mutation (Q94547384) (← links)